Palisade Bio (PALI) Preferred Shares (2016 - 2026)

Palisade Bio's (PALI) quarterly Preferred Shares came in at $2000.0 in Q1 2026, little changed year-on-year from $2000.0 in Q1 2025, and little changed on a QoQ basis from $2000.0 in Q4 2025.

Palisade Bio (PALI) Preferred Shares (2016 - 2026) Analysis & Trends

Palisade Bio (PALI) has 11 years of Preferred Shares data on file, last reported at $2000.0 in Q1 2026.

  • On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $2000.0 in Q1 2026; TTM through Mar 2026 was $2000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2000.0, changed 0.0% from the prior year.
  • Preferred Shares for Q1 2026 stood at $2000.0, roughly flat from $2000.0 in the prior quarter.
  • Over the last five years, Preferred Shares for PALI reached as high as $2000.0 in Q1 2022 and fell as low as $2000.0 in Q1 2022.
  • Historically, Preferred Shares has averaged $2000.0 across 5 years, with a median of $2000.0 in 2022.
  • On a YoY basis, Preferred Shares climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
  • Year by year, Preferred Shares stood at $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025, then changed by 0.0% to $2000.0 in 2026.
  • Per Business Quant data, the three most recent Preferred Shares figures were $2000.0 in Q1 2026, $2000.0 in Q4 2025, and $2000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Palisade Bio 985.76 -132.63 Mn - 2,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2,000.00
Dec 31, 2025 2,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 2,000.00
Sep 30, 2023 2,000.00
Jun 30, 2023 2,000.00
Mar 31, 2023 2,000.00
Dec 31, 2022 2,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 2,000.00
Mar 31, 2022 2,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 2,000.00
Jun 30, 2021 2,000.00